| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |